These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32336678)

  • 1. Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic.
    Cheng MP; Lee TC; Tan DHS; Murthy S
    CMAJ; 2020 Apr; 192(15):E405-E407. PubMed ID: 32336678
    [No Abstract]   [Full Text] [Related]  

  • 2. Multigroup, Adaptively Randomized Trials Are Advantageous for Comparing Coronavirus Disease 2019 (COVID-19) Interventions.
    Magaret AS; Jacob ST; Halloran ME; Guthrie KA; Magaret CA; Johnston C; Simon NR; Wald A
    Ann Intern Med; 2020 Oct; 173(7):576-577. PubMed ID: 32525715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Evaluation during the Covid-19 Pandemic.
    Rome BN; Avorn J
    N Engl J Med; 2020 Jun; 382(24):2282-2284. PubMed ID: 32289216
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
    Kalil AC
    JAMA; 2020 May; 323(19):1897-1898. PubMed ID: 32208486
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.
    Thomson K; Nachlis H
    JAMA; 2020 Oct; 324(13):1282-1283. PubMed ID: 32870235
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimizing the Trade-off Between Learning and Doing in a Pandemic.
    Angus DC
    JAMA; 2020 May; 323(19):1895-1896. PubMed ID: 32227198
    [No Abstract]   [Full Text] [Related]  

  • 7. Dexamethasone in the management of covid -19.
    Johnson RM; Vinetz JM
    BMJ; 2020 Jul; 370():m2648. PubMed ID: 32620554
    [No Abstract]   [Full Text] [Related]  

  • 8. Does hydroxychloroquine combat COVID-19? A timeline of evidence.
    Alia E; Grant-Kels JM
    J Am Acad Dermatol; 2020 Jul; 83(1):e33-e34. PubMed ID: 32283236
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
    Yazdany J; Kim AHJ
    Ann Intern Med; 2020 Jun; 172(11):754-755. PubMed ID: 32232419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No Easy Answers in Allocating Unapproved COVID-19 Drugs Outside Clinical Trials.
    Webb J; Shah L; Lynch HF
    Am J Bioeth; 2020 Sep; 20(9):W1-W4. PubMed ID: 32840448
    [No Abstract]   [Full Text] [Related]  

  • 11. Biggest COVID-19 trial tests repurposed drugs first.
    Nat Biotechnol; 2020 May; 38(5):510. PubMed ID: 32393915
    [No Abstract]   [Full Text] [Related]  

  • 12. A Proposed Lottery System to Allocate Scarce COVID-19 Medications: Promoting Fairness and Generating Knowledge.
    White DB; Angus DC
    JAMA; 2020 Jul; 324(4):329-330. PubMed ID: 32579158
    [No Abstract]   [Full Text] [Related]  

  • 13. BET 2: Hydroxychloroquine in the treatment of COVID-19.
    Howard L; Baombe J; Reynard C
    Emerg Med J; 2020 Jul; 37(7):451-453. PubMed ID: 32616659
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
    Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
    Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
    [No Abstract]   [Full Text] [Related]  

  • 15. Deploying Randomized Controlled Trials during the COVID-19 Pandemic: Reason and Bayesian Designs.
    Zampieri FG
    Ann Am Thorac Soc; 2020 Aug; 17(8):937-938. PubMed ID: 32735169
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19: Important Therapy Considerations and Approaches in this Hour of Need.
    Lodise TP; Rybak MJ
    Pharmacotherapy; 2020 May; 40(5):379-381. PubMed ID: 32267556
    [No Abstract]   [Full Text] [Related]  

  • 17. Chloroquine and hydroxychloroquine in covid-19.
    Ferner RE; Aronson JK
    BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
    Gao J; Hu S
    Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
    Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
    Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
    [No Abstract]   [Full Text] [Related]  

  • 20. An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19.
    Intson K; Kumar S; Botta A; Neckles R; Leung C; Jawaid A
    Swiss Med Wkly; 2020 Apr; 150():w20262. PubMed ID: 32347963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.